Jiangsu Alpha Pharmaceutical Co., Ltd.

News

Jiangsu Alpha Pharmaceutical Co., Ltd.

Exhibition Activities

We take part in leading global pharmaceutical ingredient events to present our statin, SGLT‑2 inhibitor, anti‑tumor and respiratory intermediate portfolio, including atorvastatin calcium intermediates, rosuvastatin calcium intermediates and montelukast intermediate. These activities create face‑to‑face channels for technical exchange, process discussion and joint development planning with global pharmaceutical R&D teams.

Exhibition Highlights

Jiangsu Alpha Pharmaceutical Co., Ltd.
Product Showcase

Full product portfolio on display with technical experts available for consultation.

Jiangsu Alpha Pharmaceutical Co., Ltd.
Innovation Zone

Dedicated area highlighting latest R&D achievements and green chemistry advancements.

Jiangsu Alpha Pharmaceutical Co., Ltd.
Networking Lounge

Meeting space for connecting with global partners, customers, and industry peers.

Exhibition Value

Why We Exhibit

Exhibitions serve as key windows for Jiangsu Alpha Pharmaceutical to share its latest process progress on statins, dapagliflozin, dabigatran and ibrutinib intermediates. We engage with formulation developers and process researchers to understand evolving purity and delivery requirements. Such on‑site exchanges accelerate technical alignment and promote deeper cooperation on custom intermediate development.

Brand Visibility

Showcase capabilities to a global audience of industry professionals.

Partnership Building

Establish new relationships across the chemical value chain.

Market Insight

Gather intelligence on industry direction and competitor landscape.

Client Engagement

Meet existing customers face-to-face and strengthen trust.